StockData
Tarsus Pharmaceuticals, Inc. logo

Tarsus Pharmaceuticals, Inc. (TARS) stock

TARSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/304% above fair value
$75.95−2.25 (-2.88%)

Close on Nov 18, 2026Market cap $3.33BP/E –Yield 0.00%

Tarsus Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Tarsus Pharmaceuticals's market cap was $3.32B on Nov 11, 2026, against $3.39B a year earlier. Over the last 5 years it ranged from $284.88M to $3.48B, with a median of $1.24B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.32B-4.4%
2025Dec 31, 2025$3.48B+64.3%
2024Dec 31, 2024$2.11B+215.5%
2023Dec 29, 2023$670.36M+71.4%
2022Dec 30, 2022$391.01M-15.9%
2021Dec 31, 2021$465.10M+289.7%
2020Dec 31, 2020$119.36M–

More Tarsus Pharmaceuticals figures

See a number that looks wrong?